Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
1 other identifier
observational
1,000
1 country
1
Brief Summary
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2023
CompletedFirst Submitted
Initial submission to the registry
October 3, 2024
CompletedFirst Posted
Study publicly available on registry
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
ExpectedOctober 9, 2024
October 1, 2024
2 years
October 3, 2024
October 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Bleeding
All the cases of major and minor bleeding within 1 month
1 month
Bleeding
All the cases of major and minor bleeding within 3 months
3 months
Bleeding
All the cases of major and minor bleeding within 6 months
6 months
Thromboembolism
All the cases of venous thromboembolism within 1 month
1 month
Thromboembolism
All the cases of venous thromboembolism within 3 months
3 months
Thromboembolism
All the cases of venous thromboembolism within 6 months
6 months
Study Arms (3)
Low thromboembolic risk
Moderate thromboembolic risk
High thromboembolic risk
Interventions
Eligibility Criteria
The study is planned to include 1,000 patients with cardiovascular diseases who undergo routine endoprosthetics of large joints of the lower extremities. During the follow-up, patients will be divided into subgroups depending on the scheme of perioperative prevention of thromboembolic complications and the presence of risk factors. The comparison will be carried out in the appropriate subgroups.
You may qualify if:
- Informed consent
- Age older than 18 y.o.
- Cardiovascular disease
- Indications for planned lower limb joint replacement surgery
You may not qualify if:
- Pregnancy
- Psychiatric disorders
- Decompensated heart failure or acute heart failure
- Known diagnosis of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital #1
Moscow, 119991, Russia
Related Publications (2)
Okisheva EA, Mironova OI, Berdysheva MV, Pyatigorets ES, Krivova NP, Kurnosova AA, Elizarov MP, Smetanin SM, Lychagin AV, Fomin VV. [Relationship between the pain severity, use of non-steroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities]. Ter Arkh. 2023 Nov 3;95(9):751-756. doi: 10.26442/00403660.2023.09.202373. Russian.
PMID: 38158917BACKGROUNDOkisheva EA, Trushina OY, Mamaeva MM, Redyanova EA, Zhazhieva AA, Chasova ID, Panferov AS, Bogdanov MM, Lychagin AV, Fomin VV. [Glucose metabolism disorders and hypoglycemic therapy in patients hospitalized for elective lower limb arthroplasty: a prospective, single-center, real-world study]. Ter Arkh. 2024 Jul 30;96(7):659-665. doi: 10.26442/00403660.2024.07.202780. Russian.
PMID: 39106508RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 4, 2024
Study Start
January 15, 2023
Primary Completion
January 15, 2025
Study Completion (Estimated)
January 15, 2027
Last Updated
October 9, 2024
Record last verified: 2024-10